ABOUT LINK ALTERNATIF MBL77

Not all sufferers with CLL need therapy. Despite all current innovations, the iwCLL nevertheless recommends watchful observation for individuals with asymptomatic condition.86 This advice is based on a minimum of two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).MPO77